We examine the most commercially important biotherapeutics now, and in the future.

Consumer trust in pharma nosedives because of the “blame game.”

Drug emissions in UK rivers raise questions about long-term consequences for the environment.

Artificial intelligence could have a huge impact on drug discovery.

What characteristics make a cancer therapy more likely to effectively treat disease?

Caffeine isn’t just a catalyst to get you moving in the morning – it can also help create polymers for drug delivery.

Could drug-containing QR codes fight fakes and avoid medication errors?

Why is the pharma industry overly reluctant to accept new ideas?

ISPE announce the 2018 Facility of the Year category winners…

New data protection regulations are coming.